Albemarle to supply Roche with chemicals for antiviral Tamiflu

By E. Janene Geiss

Philadelphia, March 16 - Albemarle Corp. said Thursday that it has been named as one of the production partners in the supply of intermediate chemicals for the antiviral Tamiflu (oseltamivir), produced by Roche.

Roche said Thursday in a news release that it has expanded its global manufacturing network for the production of Tamiflu to increase capacity for the product.

The company also said the manufacturing network will include several Roche sites and more than 15 external contractors, including Albemarle, in nine different countries.

The production partners for the various steps of manufacture have been selected primarily "on the basis of their ability to produce substantial quantities of intermediates and finished materials in accordance with Roche's quality standards in a relatively short time frame," Roche officials said in the release.

"Albemarle is very pleased to be part of the supply chain network Roche has assembled to produce Tamiflu," Ed Tatum, global business director for Albemarle's fine chemistry services unit, said in the release.

Albemarle, based in Richmond, Va., is a global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics, petroleum and petrochemical processing, transportation and industrial products, pharmaceuticals, agricultural products, construction and packaging materials.

Roche is a Basel, Switzerland, research-focused health care company focused on pharmaceuticals and diagnostics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.